Evidence-Based Medicine Guidelines
High-dose chemotherapy followed by autologous stem cell transplantation (HDT) as first-line therapy in aggressive non-Hodgkin's lymphoma (NHL)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"High-dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDT) as First-line Therapy in Aggressive non-Hodgkin's Lymphoma (NHL)." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452240/all/High_dose_chemotherapy_followed_by_autologous_stem_cell_transplantation__HDT__as_first_line_therapy_in_aggressive_non_Hodgkin's_lymphoma__NHL_.
High-dose chemotherapy followed by autologous stem cell transplantation (HDT) as first-line therapy in aggressive non-Hodgkin's lymphoma (NHL). Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452240/all/High_dose_chemotherapy_followed_by_autologous_stem_cell_transplantation__HDT__as_first_line_therapy_in_aggressive_non_Hodgkin's_lymphoma__NHL_. Accessed October 4, 2024.
High-dose chemotherapy followed by autologous stem cell transplantation (HDT) as first-line therapy in aggressive non-Hodgkin's lymphoma (NHL). (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452240/all/High_dose_chemotherapy_followed_by_autologous_stem_cell_transplantation__HDT__as_first_line_therapy_in_aggressive_non_Hodgkin's_lymphoma__NHL_
High-dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDT) as First-line Therapy in Aggressive non-Hodgkin's Lymphoma (NHL) [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452240/all/High_dose_chemotherapy_followed_by_autologous_stem_cell_transplantation__HDT__as_first_line_therapy_in_aggressive_non_Hodgkin's_lymphoma__NHL_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - High-dose chemotherapy followed by autologous stem cell transplantation (HDT) as first-line therapy in aggressive non-Hodgkin's lymphoma (NHL)
ID - 452240
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452240/all/High_dose_chemotherapy_followed_by_autologous_stem_cell_transplantation__HDT__as_first_line_therapy_in_aggressive_non_Hodgkin's_lymphoma__NHL_
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
